Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dodd

Showing results (321-330 of 339) with videos related to

Pageof 34
Sort By:
Journal of Medicinal Chemistry|September 9, 2011
Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826)David S Weinstein, Hua Gong, Arthur M Doweyko, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitorsJagabandhu Das, Robert V Moquin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2010
Utilization of a nitrogen-sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitorsShuqun Lin, Stephen T Wrobleski, John Hynes, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitorsJagabandhu Das, Chunjian Liu, Robert V Moquin, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinaseJames Kempson, Junqing Guo, Jagabandhu Das, et al.
Journal of Medicinal Chemistry|November 16, 2010
Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonistsBingwei V Yang, David S Weinstein, Lidia M Doweyko, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
5-amino-pyrazoles as potent and selective p38α inhibitorsJagabandhu Das, Robert V Moquin, Alaric J Dyckman, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2013
Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonistsJames E Sheppeck, John L Gilmore, Hai-Yun Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|November 20, 2010
Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritisAlaric J Dyckman, Charles M Langevine, Claude Quesnelle, et al.
Journal of Medicinal Chemistry|September 30, 2005
5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38alpha MAP kinaseChunjian Liu, Stephen T Wrobleski, James Lin, et al.
Pageof 34

Showing results (321-330 of 339) with videos related to

Sort By:
Pageof 34
Journal of Medicinal Chemistry|September 9, 2011
Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826)David S Weinstein, Hua Gong, Arthur M Doweyko, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2008
Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitorsJagabandhu Das, Robert V Moquin, Sidney Pitt, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2010
Utilization of a nitrogen-sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitorsShuqun Lin, Stephen T Wrobleski, John Hynes, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitorsJagabandhu Das, Chunjian Liu, Robert V Moquin, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinaseJames Kempson, Junqing Guo, Jagabandhu Das, et al.
Journal of Medicinal Chemistry|November 16, 2010
Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonistsBingwei V Yang, David S Weinstein, Lidia M Doweyko, et al.
Bioorganic & Medicinal Chemistry Letters|November 2, 2010
5-amino-pyrazoles as potent and selective p38α inhibitorsJagabandhu Das, Robert V Moquin, Alaric J Dyckman, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2013
Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonistsJames E Sheppeck, John L Gilmore, Hai-Yun Xiao, et al.
Bioorganic & Medicinal Chemistry Letters|November 20, 2010
Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritisAlaric J Dyckman, Charles M Langevine, Claude Quesnelle, et al.
Journal of Medicinal Chemistry|September 30, 2005
5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38alpha MAP kinaseChunjian Liu, Stephen T Wrobleski, James Lin, et al.
Pageof 34